Clinical Trials
8 trialsNCT04106856 2026-05-12
SHAPER
University of Utah
Phase 1 Active not recruiting
NCT04708067 2026-03-05
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05136846 2025-06-04
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Recruiting
NCT04951063 2023-12-15
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC
Sun Yat-sen University
Phase 1 Completed
NCT03509584 2023-06-15
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients
Assistance Publique Hopitaux De Marseille
Phase 1 Terminated
NCT02201355 2021-02-02
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
University of Texas Southwestern Medical Center
Phase 1 Terminated
NCT02383212 2020-01-27
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
Regeneron Pharmaceuticals
Phase 1 Completed
NCT02880345 2019-04-23
RADVAXâ„¢: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn